LAMIVUDINE TREATMENT FOR ONE-YEAR IN PREVIOUSLY UNTREATED US HEPATITIS-B PATIENTS - HISTOLOGIC IMPROVEMENT AND HEPATITIS BE-ANTIGEN (HBEAG)SEROCONVERSION
J. Dienstag et al., LAMIVUDINE TREATMENT FOR ONE-YEAR IN PREVIOUSLY UNTREATED US HEPATITIS-B PATIENTS - HISTOLOGIC IMPROVEMENT AND HEPATITIS BE-ANTIGEN (HBEAG)SEROCONVERSION, Gastroenterology, 114(4), 1998, pp. 148-148